| scholarly article | Q13442814 |
| P50 | author | Elaine Jaffe | Q19647268 |
| Girish Venkataraman | Q51877773 | ||
| Koneti Rao | Q86759098 | ||
| Stefania Pittaluga | Q87358458 | ||
| P2093 | author name string | Kenneth L McClain | |
| P2860 | cites work | An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome | Q33328425 |
| Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity | Q33488225 | ||
| The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis | Q33952333 | ||
| A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease | Q35604700 | ||
| Sinus histiocytosis with massive lymphadenopathy--a review of seven cases. | Q36689978 | ||
| Clonally related follicular lymphomas and histiocytic/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone. | Q36713487 | ||
| Mucosa-associated lymphoid tissue lymphoma: molecular pathogenesis and clinicopathological significance | Q36870112 | ||
| BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death | Q37572590 | ||
| Histologic features of sinus histiocytosis with massive lymphadenopathy in patients with autoimmune lymphoproliferative syndrome | Q38442307 | ||
| Constitutive NF-kappaB activation by the t(11;18)(q21;q21) product in MALT lymphoma is linked to deregulated ubiquitin ligase activity | Q40422412 | ||
| M-CSF: haematopoietic growth factor or inflammatory cytokine? | Q41722175 | ||
| Membrane-bound Fas ligand only is essential for Fas-induced apoptosis | Q42093656 | ||
| Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis | Q44455328 | ||
| Antiapoptotic function of apoptosis inhibitor 2-MALT1 fusion protein involved in t(11;18)(q21;q21) mucosa-associated lymphoid tissue lymphoma | Q44901053 | ||
| Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome | Q55670225 | ||
| Autoimmune Lymphoproliferative Syndrome (ALPS) Caused by Fas (CD95) Mutation Mimicking Sarcoidosis | Q58956859 | ||
| Involvement of the bcl-2 gene in human follicular lymphoma | Q69870224 | ||
| Evidence for a polyclonal nature of the cell infiltrate in sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease) | Q70861981 | ||
| Characteristic T helper 2 T cell cytokine abnormalities in autoimmune lymphoproliferative syndrome, a syndrome marked by defective apoptosis and humoral autoimmunity | Q73064451 | ||
| Sinus histiocytosis with massive lymphadenopathy: evidence for its relationship to macrophages and for a cytokine-related disorder | Q73231934 | ||
| Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expression | Q73850215 | ||
| The clinical spectrum in a large kindred with autoimmune lymphoproliferative syndrome caused by a Fas mutation that impairs lymphocyte apoptosis | Q77577103 | ||
| Rosai-Dorfman disease (sinus histiocytosis with massive lymphadenopathy) of the pancreas: first case report | Q77887625 | ||
| IL-4 and IL-10 inhibition of spontaneous monocyte apoptosis is associated with Flip upregulation | Q80965351 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | autoimmune lymphoproliferative syndrome | Q1151300 |
| histiocytic sarcoma | Q5773034 | ||
| patient | Q181600 | ||
| P304 | page(s) | 589-594 | |
| P577 | publication date | 2010-04-01 | |
| P1433 | published in | The American Journal of Surgical Pathology | Q7713508 |
| P1476 | title | Development of disseminated histiocytic sarcoma in a patient with autoimmune lymphoproliferative syndrome and associated Rosai-Dorfman disease | |
| P478 | volume | 34 |
| Q34393868 | Autoimmune Lymphoproliferative Syndrome and Epstein-Barr Virus-Associated Lymphoma: An Adjunctive Diagnostic Role for Monitoring EBV Viremia? |
| Q26825740 | Autoimmune lymphoproliferative syndrome: an update and review of the literature |
| Q37618832 | Bone marrow findings in autoimmune lymphoproliferative syndrome with germline FAS mutation |
| Q85161359 | Histiocytic sarcoma with two immunohistopathologically distinct populations |
| Q24633207 | How I treat autoimmune lymphoproliferative syndrome |
| Q88270764 | Is Rosai-Dorfman disease a reactve process? Detection of a MAP2K1 L115V mutation in a case of Rosai-Dorfman disease |
| Q37670054 | Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations |
| Q39232124 | Primary/Congenital Immunodeficiency: 2015 SH/EAHP Workshop Report-Part 5. |
| Q42127711 | Rosai-Dorfman Disease Harboring an Activating KRAS K117N Missense Mutation. |
| Q34886422 | Rosai-Dorfman disease: a report of eight cases in a tertiary care center and a review of the literature |
| Q51136643 | Successful treatment of pediatric histiocytic sarcoma using abbreviated high-risk leukemia chemotherapy. |
| Q37834406 | Synchronous histiocytic sarcoma and diffuse large B cell lymphoma involving the stomach: a case report and review of the literature |
| Q38194538 | Updates on histiocytic disorders. |
Search more.